Today stock markets tried to rise higher but I have to go get my covid-19 shot and cannot watch the movements. US Covid-19 cases came in at under 100,000 which is hopeful if it reflects inoculations, down 56% from the previous level. But it may be a statistical fluke.

The big news is that Teva fell sharply despite surprisingly good earnings and news that it was close to a settlement over its opioid sales violations. 

Uranium was the latest metal flying high. The theft of exhaust cleaning devices from posh cars made the headlines, but the makers and refiners of platinum devices have yet to rise.

Markets penalized companies doing secondary capital increases notable our Enlivex.

CBOE which I have been boosting of late has joined the attempt by Nasdaq and the NYSE to stop the SEC rule requiring that investors get market price data so they can see what their shares are worth. The exchanges and CBOE sell this data to brokers and they say the free delivery is an unconstitutional seizure of property. I am conflicted as I dote on price data and aim to explain it daily, but I am also a shareholder in CBOE directly and in Nasdaq through our Swedish holding company.